Quality of life in patients with choroidal melanoma

A pilot study

B. Michele Melia, Claudia S. Moy, Lee McCaffrey

Research output: Contribution to journalArticle

Abstract

PURPOSE: To assess the internal consistency of a short, widely-used health-related quality of life instrument in patients with choroidal melanoma, its appropriateness for use in a large clinical trial in patients with that disease, and the feasibility of various methods of instrument administration METHODS: The SF-36 was administered to 31 choroidal melanoma patients identified from two ocular oncology practices. Fifteen patients were interviewed by telephone, 4 were interviewed in person at the clinic, and 12 patients completed the instrument themselves while at the clinic. RESULTS: Twenty-three patients had already been treated for choroidal melanoma; 20 patients were treated with some form of radiation. The remaining 8 patients had not yet been treated. Metastasis had not been diagnosed in any of the patients. Patient age ranged from 37 to 85 years with a median of 59 years; 55% of the patients were female. The in-person and telephone interviews performed better than self-administered interviews in terms of missing items due to non-response (0% vs. 3.2%). The overall SF-36 health profile for the choroidal melanoma patients was similar in shape to that expected for a general U.S. population sample with the same age and gender distribution, although the choroidal melanoma patients averaged 4 to 11 points higher, indicating better health-related quality of life, for all scales except the role functioning-emotional scale. CONCLUSIONS: The results supported the internal consistency of the SF-36 in this population. Interviewer administration of the SF-36 either in-person or by telephone was acceptable to the patients and provided more complete data.

Original languageEnglish (US)
Pages (from-to)19-28
Number of pages10
JournalOphthalmic Epidemiology
Volume6
Issue number1
DOIs
StatePublished - 1999

Fingerprint

Melanoma
Quality of Life
Interviews
Telephone
Age Distribution
Population
Clinical Trials
Radiation
Neoplasm Metastasis

Keywords

  • Choroidal melanoma
  • Quality of life
  • Questionnaire study

ASJC Scopus subject areas

  • Ophthalmology
  • Epidemiology

Cite this

Quality of life in patients with choroidal melanoma : A pilot study. / Melia, B. Michele; Moy, Claudia S.; McCaffrey, Lee.

In: Ophthalmic Epidemiology, Vol. 6, No. 1, 1999, p. 19-28.

Research output: Contribution to journalArticle

Melia, B. Michele ; Moy, Claudia S. ; McCaffrey, Lee. / Quality of life in patients with choroidal melanoma : A pilot study. In: Ophthalmic Epidemiology. 1999 ; Vol. 6, No. 1. pp. 19-28.
@article{f21e490540404a5da4c487a7b6b1e9fd,
title = "Quality of life in patients with choroidal melanoma: A pilot study",
abstract = "PURPOSE: To assess the internal consistency of a short, widely-used health-related quality of life instrument in patients with choroidal melanoma, its appropriateness for use in a large clinical trial in patients with that disease, and the feasibility of various methods of instrument administration METHODS: The SF-36 was administered to 31 choroidal melanoma patients identified from two ocular oncology practices. Fifteen patients were interviewed by telephone, 4 were interviewed in person at the clinic, and 12 patients completed the instrument themselves while at the clinic. RESULTS: Twenty-three patients had already been treated for choroidal melanoma; 20 patients were treated with some form of radiation. The remaining 8 patients had not yet been treated. Metastasis had not been diagnosed in any of the patients. Patient age ranged from 37 to 85 years with a median of 59 years; 55{\%} of the patients were female. The in-person and telephone interviews performed better than self-administered interviews in terms of missing items due to non-response (0{\%} vs. 3.2{\%}). The overall SF-36 health profile for the choroidal melanoma patients was similar in shape to that expected for a general U.S. population sample with the same age and gender distribution, although the choroidal melanoma patients averaged 4 to 11 points higher, indicating better health-related quality of life, for all scales except the role functioning-emotional scale. CONCLUSIONS: The results supported the internal consistency of the SF-36 in this population. Interviewer administration of the SF-36 either in-person or by telephone was acceptable to the patients and provided more complete data.",
keywords = "Choroidal melanoma, Quality of life, Questionnaire study",
author = "Melia, {B. Michele} and Moy, {Claudia S.} and Lee McCaffrey",
year = "1999",
doi = "10.1076/opep.6.1.19.1570",
language = "English (US)",
volume = "6",
pages = "19--28",
journal = "Ophthalmic Epidemiology",
issn = "0928-6586",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Quality of life in patients with choroidal melanoma

T2 - A pilot study

AU - Melia, B. Michele

AU - Moy, Claudia S.

AU - McCaffrey, Lee

PY - 1999

Y1 - 1999

N2 - PURPOSE: To assess the internal consistency of a short, widely-used health-related quality of life instrument in patients with choroidal melanoma, its appropriateness for use in a large clinical trial in patients with that disease, and the feasibility of various methods of instrument administration METHODS: The SF-36 was administered to 31 choroidal melanoma patients identified from two ocular oncology practices. Fifteen patients were interviewed by telephone, 4 were interviewed in person at the clinic, and 12 patients completed the instrument themselves while at the clinic. RESULTS: Twenty-three patients had already been treated for choroidal melanoma; 20 patients were treated with some form of radiation. The remaining 8 patients had not yet been treated. Metastasis had not been diagnosed in any of the patients. Patient age ranged from 37 to 85 years with a median of 59 years; 55% of the patients were female. The in-person and telephone interviews performed better than self-administered interviews in terms of missing items due to non-response (0% vs. 3.2%). The overall SF-36 health profile for the choroidal melanoma patients was similar in shape to that expected for a general U.S. population sample with the same age and gender distribution, although the choroidal melanoma patients averaged 4 to 11 points higher, indicating better health-related quality of life, for all scales except the role functioning-emotional scale. CONCLUSIONS: The results supported the internal consistency of the SF-36 in this population. Interviewer administration of the SF-36 either in-person or by telephone was acceptable to the patients and provided more complete data.

AB - PURPOSE: To assess the internal consistency of a short, widely-used health-related quality of life instrument in patients with choroidal melanoma, its appropriateness for use in a large clinical trial in patients with that disease, and the feasibility of various methods of instrument administration METHODS: The SF-36 was administered to 31 choroidal melanoma patients identified from two ocular oncology practices. Fifteen patients were interviewed by telephone, 4 were interviewed in person at the clinic, and 12 patients completed the instrument themselves while at the clinic. RESULTS: Twenty-three patients had already been treated for choroidal melanoma; 20 patients were treated with some form of radiation. The remaining 8 patients had not yet been treated. Metastasis had not been diagnosed in any of the patients. Patient age ranged from 37 to 85 years with a median of 59 years; 55% of the patients were female. The in-person and telephone interviews performed better than self-administered interviews in terms of missing items due to non-response (0% vs. 3.2%). The overall SF-36 health profile for the choroidal melanoma patients was similar in shape to that expected for a general U.S. population sample with the same age and gender distribution, although the choroidal melanoma patients averaged 4 to 11 points higher, indicating better health-related quality of life, for all scales except the role functioning-emotional scale. CONCLUSIONS: The results supported the internal consistency of the SF-36 in this population. Interviewer administration of the SF-36 either in-person or by telephone was acceptable to the patients and provided more complete data.

KW - Choroidal melanoma

KW - Quality of life

KW - Questionnaire study

UR - http://www.scopus.com/inward/record.url?scp=0033030732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033030732&partnerID=8YFLogxK

U2 - 10.1076/opep.6.1.19.1570

DO - 10.1076/opep.6.1.19.1570

M3 - Article

VL - 6

SP - 19

EP - 28

JO - Ophthalmic Epidemiology

JF - Ophthalmic Epidemiology

SN - 0928-6586

IS - 1

ER -